Skin Cancer, Thyroid Cancer,
Showing 9976 - 10000 of >10,000
Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab, Capecitabine,
Completed
- Metastatic Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Ramucirumab
- +4 more
-
Fayetteville, Arkansas
- +134 more
Jul 29, 2021
NSCLC Metastatic Trial in Naestved, Aalborg, Vejle (Circulating tumor DNA treatment monitoring)
Not yet recruiting
- Non-small Cell Lung Cancer Metastatic
- Circulating tumor DNA treatment monitoring
-
Naestved, Zealand, Denmark
- +2 more
May 25, 2023
Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma of the Salivary Gland Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Adenoid Cystic Carcinoma
- Adenoid Cystic Carcinoma of the Salivary Gland
- Implantable Microdevice (IMD)
-
Boston, Massachusetts
- +1 more
Sep 22, 2022
Metastatic Colorectal Cancer, BRAF V600E Mutation Positive Trial in France (Collection of blood samples)
Not yet recruiting
- Metastatic Colorectal Cancer
- BRAF V600E Mutation Positive
- Collection of blood samples
-
Avignon, France
- +26 more
Nov 25, 2022
Colorectal Cancer, Colorectal Carcinoma Trial in United States (Risk Factor Questionnaire)
Recruiting
- Colorectal Cancer
- Colorectal Carcinoma
- Risk Factor Questionnaire
-
Basking Ridge, New Jersey
- +7 more
Oct 4, 2021
Melanoma (Skin) Trial (Sodium Chloride Granules, Water)
Not yet recruiting
- Melanoma (Skin)
- Sodium Chloride Granules
- Water
- (no location specified)
May 2, 2023
Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening Trial (Changes in CRC screening awareness and
Not yet recruiting
- Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening
- Changes in CRC screening awareness and intentions
- (no location specified)
Jun 30, 2023
HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)
Recruiting
- HER2-positive Breast Cancer
- HER-2 pulsed DC1
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Oct 6, 2022
Cancer, Tumors Trial in Liverpool, Bebington (ACIT-1)
Recruiting
- Cancer
- Neoplasms
- ACIT-1
-
Liverpool, Merseyside, United Kingdom
- +1 more
Feb 24, 2022
Metastatic Castration Resistant Prostate Cancer Trial in China (AC176)
Not yet recruiting
- Metastatic Castration Resistant Prostate Cancer
-
Beijing, China
- +4 more
Jan 4, 2023
Cigarette Smoker, Current Every Day Smoker Trial in Columbus (procedure, drug, other)
Recruiting
- Cigarette Smoker
- Current Every Day Smoker
- Bronchoscopy with Bronchoalveolar Lavage
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jan 5, 2023
Breast Cancer, Treatment Side Effects, Advanced Breast Cancer Trial in Shanghai (Tumor Infiltrating Lymphocytes (TIL))
Recruiting
- Breast Cancer
- +3 more
- Tumor Infiltrating Lymphocytes (TIL)
-
Shanghai, ChinaShanghai Tenth People's Hospital
Dec 19, 2022
Malignant Tumor of Prostate Trial in Cleveland ([F-18] NaF PET/CT, [F-18] fluciclovine PET/CT)
Withdrawn
- Malignant Neoplasm of Prostate
- [F-18] NaF PET/CT
- [F-18] fluciclovine PET/CT
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Mar 21, 2022
Lung Cancer Trial in Manchester (Once daily radiotherapy, Twice daily radiotherapy)
Completed
- Lung Cancer
- Once daily radiotherapy
- Twice daily radiotherapy
-
Manchester, United KingdomThe Christie NHS Foundation Trust
Sep 5, 2022
Colon Cancer Trial in Hyderabad (sentinel lymph node mapping)
Completed
- Colon Cancer
- sentinel lymph node mapping
-
Hyderabad, Telangana, IndiaAsian Institute of Gastroenterology
Jul 3, 2022
Single Patient Classifier Prediction for Stage II and III
Recruiting
- Gastric Cancer
-
Seoul, Korea, Republic ofNovomics. Co., Ltd.
Jul 21, 2022
Platinum-resistant Epithelial Ovarian Cancer Trial in Ocala, Mineola (Maveropepimut-S, Cyclophosphamide 50mg)
Recruiting
- Platinum-resistant Epithelial Ovarian Cancer
- Maveropepimut-S
- Cyclophosphamide 50mg
-
Ocala, Florida
- +1 more
Jul 20, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
Breast Cancer Lymphedema Trial in Tianjin (local distribution points association, local-distal points association)
Completed
- Breast Cancer Lymphedema
- local distribution points association
- local-distal points association
-
Tianjin, Tianjin, ChinaBaokang Hospital Affiliated to Tianjin University of Traditional
Apr 30, 2021
Oligometastatic Prostate Carcinoma Trial in China (ADT combined with abiraterone, neoadjuvant hormone and RT)
Not yet recruiting
- Oligometastatic Prostate Carcinoma
- ADT combined with abiraterone
- neoadjuvant hormone and RT
-
Hefei, Anhui, China
- +5 more
Jan 28, 2023
Laryngeal Squamous Cell Carcinoma, Stage II Laryngeal Cancer AJCC v8, Stage III Laryngeal Cancer AJCC v8 Trial in Houston
Recruiting
- Laryngeal Squamous Cell Carcinoma
- +2 more
- Carboplatin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
Multiple Myeloma-Light Chain Only, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (drug,
Terminated
- Multiple Myeloma-Light Chain Only
- +2 more
- Dexamethasone
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2021
Aging Trial in Paris (injection, Cream application)
Completed
- Aging
- injection
- Cream application
-
Paris, FranceDr Jean-Jacques DEUTSCH
Nov 7, 2022